Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

50 та иш

Иш: Alterations in 3D Chromatin Spatial Organisation in Tumourigenesis and Therapy Resistance of Glioblastoma: The Recent Advances in Understanding Molecular Mechanisms, Clinical Implications, and Therapeutic Perspectives

  1. Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies

    Ding-Ya Sun, Yijie Hu, Xin Li +3

    Шарҳ мақола20247 иқтибос
    ABI

  2. A <scp>TGF</scp>‐β signaling‐related <scp>lncRNA</scp> signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response

    Weiwei Duan, Liting Yang, Jian Liu +13

    Мақола20236 иқтибос
    ABI

  3. m6A-Mediated Upregulation of lncRNA CHASERR Promotes the Progression of Glioma by Modulating the miR-6893-3p/TRIM14 Axis

    Xingwei Wu, Minjie Fu, Chang Ge +9

    Мақола20244 иқтибос
    ABI

  4. TMEM64 aggravates the malignant phenotype of glioma by activating the Wnt/β-catenin signaling pathway

    Hui Yang, Hanyu Zhou, Minjie Fu +7

    Мақола20244 иқтибос
    ABI

  5. Nanocarriers in glioblastoma treatment: a neuroimmunological perspective

    Faezeh Firuzpour, Kiarash Saleki, Cena Aram +1

    Шарҳ мақола20244 иқтибос
    ABI

  6. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017

    Quinn T. Ostrom, Nirav Patil, Gino Cioffi +3

    Мақола20204 иқтибос
    ABI

  7. The HER2 target for designing novel multi-peptide vaccine against breast cancer using immunoinformatics and molecular dynamic simulation

    Faezeh Firuzpour, Maryam Barancheshmeh, Fariba Fallah Ziarani +2

    Мақола20253 иқтибос
    ABI

  8. Targeting EZH2 in cancer

    Kimberly H. Kim, Charles W.M. Roberts

    Шарҳ мақола20162 иқтибос
    ABI

  9. Сарлавҳасиз

    Бошқа2 иқтибос
    ABI

  10. Сарлавҳасиз

    Бошқа2 иқтибос
    ABI

  11. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

    Roger Stupp, Monika E. Hegi, Warren Mason +21

    Мақола20092 иқтибос
    ABI

  12. The Microenvironmental Landscape of Brain Tumors

    Daniela F. Quail, Johanna A. Joyce

    Шарҳ мақола20172 иқтибос
    ABI

  13. Machine learning for multi-omics data integration in cancer

    Zhaoxiang Cai, Rebecca C. Poulos, Jia Liu +1

    Шарҳ мақола20222 иқтибос
    ABI

  14. Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma

    Zan Liu, Zitong Zhao, Longlong Xie +4

    Мақола20252 иқтибос
    ABI

  15. Therapeutic targeting of triple-negative breast cancer: A multi-model evaluation of LNA-anti-miR-19b-3p and small molecule inhibitors

    Mohammad Javad Kamali, Fatemeh Saeedi, Azin Khoshghiafeh +3

    Мақола20252 иқтибос
    ABI

  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI